Showing results (31-40 of 66) with videos related to
Sort By:
Pageof 7
Experimental Gerontology|June 23, 2009
Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI)Katharina Buerger, Giovanni Frisoni, Olga Uspenskaya, et al.Neuroepidemiology|October 19, 2013
Preserving cognition, quality of life, physical health and functional ability in Alzheimer's disease: the effect of physical exercise (ADEX trial): rationale and designKristine Hoffmann, Kristian S Frederiksen, Nanna Aue Sobol, et al.Journal of Neuroimmunology|September 9, 2018
Inflammatory markers of CHMP2B-mediated frontotemporal dementiaPeter Roos, Marina Rode von Essen, Troels Tolstrup Nielsen, et al.Neurobiology of Aging|September 11, 2017
TMEM106B and ApoE polymorphisms in CHMP2B-mediated frontotemporal dementia (FTD-3)Nina Rostgaard, Peter Roos, Esben Budtz-Jørgensen, et al.Acta Neurologica Scandinavica|January 8, 2022
Six generations of CHMP2B-mediated Frontotemporal Dementia: Clinical features, predictive testing, progression, and survivalPeter Roos, Peter Johannsen, Suzanne G Lindquist, et al.Acta Neuropathologica|September 12, 2015
Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathologyEmma L Clayton, Sarah Mizielinska, James R Edgar, et al.Journal of Alzheimer'S Disease : JAD|October 7, 2017
Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and CognitionBabette L R Reijs, Inez H G B Ramakers, Lyzel Elias-Sonnenschein, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 18, 2008
The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease ConsortiumGiovanni B Frisoni, Wouter J P Henneman, Michael W Weiner, et al.Journal of Alzheimer'S Disease : JAD|October 7, 2017
Memory Correlates of Alzheimer's Disease Cerebrospinal Fluid Markers: A Longitudinal Cohort StudyBabette L R Reijs, Inez H G B Ramakers, Sebastian Köhler, et al.The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Point of view: Challenges in implementation of new immunotherapies for Alzheimer's diseaseSandar Aye, Gunilla Johansson, Christoph Hock, et al.Pageof 7